0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Translational Science With Clinical Promise |

Vision Preservation With Neural Stem Cells Derived From Small Molecules

Marco Zarbin, MD, PhD
JAMA Ophthalmol. 2013;131(2):244-245. doi:10.1001/jamaophthalmol.2013.2664.
Text Size: A A A
Published online

Extract

Stem cells are unspecialized cells with the capacity for unlimited self-renewal. Each daughter cell has the capacity to remain a stem cell or to differentiate into more specialized, tissue-specific or organ-specific cells.1 Human embryonic stem cells (hESCs), derived from the inner cell mass of the blastocyst, are pluripotent, which means they can form all lineages of the body (ectoderm, mesoderm, and endoderm). Adult cells can be reprogrammed to an embryonic state using somatic nuclear cell transfer. (This is the technique that was used to create Dolly the sheep.) Adult cells also can be genetically reprogrammed to an embryonic stem cell–like state by being forced to express transcription factors (eg, c -Myc, Sox-2, and Klf4) using retroviruses or lentiviruses.24 Although the therapeutic potential of induced pluripotent stem cells has been demonstrated in animal models of human diseases (eg, sickle cell anemia), these induced pluripotent stem cells have contained multiple viral vector integrations that make them unsuitable for human clinical trials. The use of genome-integrating viruses can cause insertional mutagenesis and unpredictable genetic dysfunction. The oncogenic properties of some transcription factors (eg, c -Myc) also create safety concerns. A number of different strategies are being developed to overcome these obstacles such as development of modified protocols that do not require c -Myc, Sox-2, and/or Klf4 or using expression plasmids rather than integrating viral vectors to deliver the transcription factors. Other strategies to reprogram cells to pluripotency have used modified synthetic messenger RNA or recombinant proteins that can penetrate the plasma membrane of somatic cells or even exposing somatic cells to embryonic stem cell–conditioned media. One or more of these strategies may be safer than using viral vectors to induce reprogramming. Ongoing progress in this area will usher in the era of regenerative medicine.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();